FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

Recruiting

Neoadjuvant ChemotherapyFIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

Sponsor:

University Health Network, Toronto

Code:

NCT04016389

Conditions

Cervical Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 40

Healthy Volunteers: Not accepted

Interventions

Cisplatin

Carboplatin

Paclitaxel

Trachelectomy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-17. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2025-08-12.